Therapeutic potential of IFN-γ-modified dendritic cells in acute and chronic experimental allergic encephalomyelitis
スポンサーリンク
概要
- 論文の詳細を見る
- 2004-01-01
著者
-
Bjelke Borje
Mrc Department Of Clinical Neuroscience Karolinska Institute
-
Xu Ling-yun
Division Of Neuroimmunology Neurotec Karolinska Institute
-
Wu Xing-chen
Mrc Department Of Clinical Neuroscience Karolinska Institute
-
LINK Hans
Division of Neurology, Karolinska Institute, Huddinge University Hospital
-
XIAO Bao-Guo
Division of Neurology, Karolinska Institute, Huddinge University Hospital
-
WU Xing-Chen
MRC, Department of Clinical Neuroscience, Karolinska Institute
-
YANG Jian-She
Division of Neuroimmunology, Neurotec, Karolinska Institute
-
LIU Xuan
Division of Neuroimmunology, Neurotec, Karolinska Institute
-
HUANG Yu-Min
Division of Neuroimmunology, Neurotec, Karolinska Institute
-
BJELKE Borje
MRC, Department of Clinical Neuroscience, Karolinska Institute
-
Liu Xuan
Division Of Neuroimmunology Neurotec Karolinska Institute
-
Link Hans
Division Of Neuroimmunology Neurotec Karolinska Institute
-
Huang Yu-min
Division Of Neuroimmunology Neurotec Karolinska Institute
-
Xiao Bao-guo
Division Of Neuroimmunology Neurotec Karolinska Institute
-
Yang Jian-she
Division Of Neuroimmunology Neurotec Karolinska Institute
関連論文
- Experimental autoimmune myasthenia gravis induction in B cell-deficient mice
- Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99
- Therapeutic potential of IFN-γ-modified dendritic cells in acute and chronic experimental allergic encephalomyelitis
- Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against experimental autoimmune encephalomyelitis by inducing gransforming growth factor-β-secreting cells and suppressing chemokine expression